Innovative solutions for the treatment of cardiac arrhythmia

Doron Harlev
CEO, Founder

Doron is the founder and CEO of Affera, Inc. Prior to Affera, Doron co-founded and served as co-CEO at Rhythmia Medical, which developed a unique Electroanatomical Mapping System for the treatment of Cardiac Arrhythmia. Acquired by Boston Scientific in 2012, Rhythmia became Boston Scientific’s cardiac mapping and navigation division, where Doron served as Vice President of Product and Technology. Prior to Rhythmia, Doron held a variety of roles in an elite R&D unit in the Israeli Ministry of Defense.

Doron is a prolific inventor holding over 160 issued and pending patents. He is currently an advisor to a number of start-up companies, and serves as a Board member at Lexington Medical, Inc. Doron holds an MBA from MIT Sloan, M.Sc. EE from Tel Aviv University and B.Sc. EE from the Technion Israel Institute of Technology.

Leon Amariglio
Board Member

Leon currently serves as the CEO of Lexington Medical, Inc. Previously, Leon co-founded Rhythmia with Doron and served as Vice President at Boston Scientific upon Rhythmia’s acquisition.

Prior to Rhythmia, Leon led business development at Ceragon Networks Ltd, a wireless equipment provider, and worked at Deutsche Bank Alex. Brown leading financing and mergers and acquisition transactions. Leon holds an MBA degree from Harvard Business School and a Masters of Engineering degree from the University of Cambridge.

Jeffrey Schwartz
Board Member

Jeffrey Schwartz joined Bain Capital in 2004 and is a Managing Director. Prior to his current role, he was a member of Bain Capital’s Private Equity team, where he focused on healthcare investments. Prior to joining Bain Capital, Mr. Schwartz served as an Equity Research Analyst at Lehman Brothers, where he was focused on the aerospace and defense industries working in both New York and London.

Mr. Schwartz received an MBA from The Wharton School at the University of Pennsylvania, where he was a Palmer Scholar and he graduated magna cum laude from Yale University with a BA in economics.

Aaron Sandoski
Board Member

Aaron is a Founding Partner of the Medtech Convergence Fund and Managing Director of Norwich Ventures, an early-stage medtech VC he co-founded in 2004. He has been an investor in the first venture round of numerous medtech companies including Affera, Alpheus Medical, IonPath, Lexington Medical, Podimetrics, Vaxess, Intelligent Bio-systems (acquired by Qiagen), Pelvalon (acquired by Laborie Medical) and Rhythmia Medical (acquired by Boston Scientific). Previously, Aaron worked for DEKA, the engineering think tank of Dean Kamen, and two start-up companies that exited in acquisitions. Aaron began his career as a consultant at McKinsey & Company.

Aaron serves on the Board of MassMEDIC and regularly guest lectures on medical technology, innovation, and finance at Harvard and Stanford. He is the author of How the Wise Decide, a book on decision-making that has been translated into 11 foreign languages. Aaron enjoys finding new adventures with his family and is passionate about classic cars.

Aaron received an MBA from Harvard Business School and he graduated summa cum laude from Dartmouth College with a double BA in Economics and Chemistry.